Skip to Content

Join the 'HIV Infection' group to help and get support from people like you.

HIV Infection News

Related terms: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome (AIDS), Acute HIV Infection, Acute Retroviral Syndrome, AIDS, AIDS-Related Complex, Chronic Symptomatic HIV Infection, HIV Infection, Acute, HIV Seroconversion Syndrome, Human Immunodeficiency Virus Infection, Primary HIV Infection, HIV, ARC, Acquired Immunodeficiency Syndrome, HIV/AIDS

Antiviral Treatments Reduce Cancer Risk for HIV Patients

Posted 8 days ago by Drugs.com

MONDAY, June 11, 2018 – Long-term antiviral treatment cuts the risk of cancer in HIV patients as they age, a new study says. People with HIV are at increased risk for both AIDS-related cancers (Kaposi sarcoma, non-Hodgkin lymphoma or invasive cervical cancer) and non-AIDS-related cancers (lung and larynx cancer, melanoma and leukemia). Antiretroviral therapy (ART) is a major part of HIV ...

Human Trials Set for Experimental HIV Vaccine

Posted 13 days ago by Drugs.com

WEDNESDAY, June 6, 2018 – An experimental HIV vaccine protected animals from dozens of strains of HIV. And a human trial of the vaccine is expected to begin in the second half of 2019, according to U.S. researchers. The vaccine targets a vulnerable site on HIV – the virus that causes AIDS – and triggered antibody production in mice, guinea pigs and monkeys, according to researchers with the ...

FDA Medwatch Alert: Juluca, Tivicay, Triumeq (dolutegravir): FDA to Evaluate - Potential Risk of Neural Tube Birth Defects

Posted 20 May 2018 by Drugs.com

ISSUE: Serious cases of neural tube birth defects involving the brain, spine, and spinal cord have been reported in babies born to women treated with dolutegravir used to treat human immunodeficiency virus (HIV). Preliminary results from an ongoing observational study in Botswana found that women who received dolutegravir at the time of becoming pregnant or early in the first trimester appear to ...

AHA: The Link Between HIV and High Blood Pressure

Posted 18 May 2018 by Drugs.com

FRIDAY, May 18, 2018 (American Heart Association) – People with HIV are more likely than people without the virus to have high blood pressure, in part because of treatments and repercussions of the condition itself, a new review of research shows. Learning more about the underlying mechanisms of high blood pressure in people with HIV is critical in preventing one of the leading conditions that ...

FDA Approves Expanded Indication for Truvada (emtricitabine and tenofovir disoproxil fumarate) for Reducing the Risk of Acquiring HIV-1 in Adolescents

Posted 16 May 2018 by Drugs.com

FOSTER CITY, Calif.--(BUSINESS WIRE)--May 15, 2018-- Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Truvada (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)—in combination with safer sex practices—to reduce the risk of sexually acquired HIV-1 in at-risk adolescents. The safety and efficacy profile of Tru ...

HIV Drug, Tenofovir, Appears Safe During Pregnancy

Posted 26 Apr 2018 by Drugs.com

WEDNESDAY, April 25, 2018 – Drugs to prevent HIV-positive pregnant women from infecting their unborn babies appear safe and don't raise the risk for premature birth or infant death, new research indicates. The U.S. scientists said their findings should ease worries among expectant mothers treated with antiviral regimens that contain the drug tenofovir disoproxil fumarate (TDF). "The analysis ...

Mylan Introduces Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate) Triple Combo Once-Daily HIV Treatment in the U.S.

Posted 8 Apr 2018 by Drugs.com

HERTFORDSHIRE, England and PITTSBURGH, March 28, 2018 /PRNewswire/ – Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will introduce in the U.S. a third cost-saving HIV combination. The U.S. Food and Drug Administration (FDA) approved Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate) 600 mg/300 mg/300 mg tablets, a once-daily, single-tablet regimen ...

Mylan Introduces Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate) Triple Combo Once-Daily HIV Treatment in the U.S.

Posted 8 Apr 2018 by Drugs.com

HERTFORDSHIRE, England and PITTSBURGH, March 28, 2018 /PRNewswire/ – Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will introduce in the U.S. a third cost-saving HIV combination. The U.S. Food and Drug Administration (FDA) approved Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate) 600 mg/300 mg/300 mg tablets, a once-daily, single-tablet regimen ...

U.S. Deaths From Infectious Diseases Decline, But Not Everywhere

Posted 27 Mar 2018 by Drugs.com

TUESDAY, March 27, 2018 – Though fewer Americans are now dying from infectious diseases, great disparities persist across the country, a new study finds. Between 1980 and 2014, just over 4 million Americans died from infectious diseases. But while overall infectious disease deaths have dropped almost 19 percent, death rates differed widely by county. A number of factors fuel these disparities, ...

FDA Approves Trogarzo (ibalizumab-uiyk) for Treatment-Experienced Patients with Multidrug Resistant HIV

Posted 12 Mar 2018 by Drugs.com

March 6, 2018 – Today, the U.S. Food and Drug Administration approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies (multidrug resistant HIV, or MDR HIV). ...

New Medication Trogarzo Approved for Drug-Resistant HIV

Posted 12 Mar 2018 by Drugs.com

TUESDAY, March 6, 2018 – Trogarzo (ibalizumab-uiyk) has been approved by the U.S. Food and Drug Administration to treat AIDS-causing HIV that has not responded to other antiretroviral medications. Trogarzo is given intravenously once every 14 days in combination with other antiretroviral drugs, the FDA said Tuesday in a news release. "While most patients living with HIV can be successfully ...

Mylan to Introduce Cimduo (lamivudine and tenofovir disoproxil fumarate) as a New Cost-Saving HIV Combination Treatment in the U.S.

Posted 12 Mar 2018 by Drugs.com

HERTFORDSHIRE, England and PITTSBURGH, March 2, 2018 /PRNewswire/ – Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will launch Cimduo, which was approved in February by the U.S. Food and Drug Administration (FDA). Mylan anticipates introducing Cimduo in the second quarter of this year. This upcoming launch will extend Mylan's global antiretroviral (ARV) platform ...

Mylan to Introduce Symfi Lo (efavirenz, lamivudine and tenofovir disoproxil fumarate) as a New Cost-Saving HIV Combination Treatment in the U.S.

Posted 12 Mar 2018 by Drugs.com

HERTFORDSHIRE, England and PITTSBURGH, March 2, 2018 /PRNewswire/ – Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will launch a new HIV treatment, Symfi Lo, which was approved in February by the U.S. Food and Drug Administration (FDA). Mylan anticipates introducing Symfi Lo in the coming weeks. This upcoming launch will extend Mylan's global antiretroviral (ARV) ...

FDA Approves Biktarvy (bictegravir, emtricitabine, tenofovir alafenamide) for Treatment of HIV-1 Infection

Posted 8 Feb 2018 by Drugs.com

FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 7, 2018-- Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF), a once-daily single tablet regimen (STR) for the treatment of HIV-1 infection. Biktarvy combines the novel, unboosted integrase strand transfer ...

Scientists Zero in on Better Saliva-Based HIV Test

Posted 29 Jan 2018 by Drugs.com

MONDAY, Jan. 29, 2018 – An experimental saliva-based HIV test shows promise, researchers report. The new test may be able to detect early evidence of HIV antibodies in saliva as reliably as a blood test, according to the scientists who developed it. The antibodies are produced by the immune system to fight HIV, the virus that causes AIDS. "The earlier you can detect, the better, because people ...

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Pre-Exposure Prophylaxis, Viral Infection

Related Drug Support Groups

Atripla, Truvada, Triumeq, Stribild, Genvoya, Complera, tenofovir, Viread, Prezista, view more... Norvir, lamivudine, Kaletra, Combivir, ritonavir, Carimune, abacavir, efavirenz, Odefsey, immune globulin intravenous, Trogarzo, nevirapine, Descovy, Symfi Lo, Reyataz, Cimduo, Viramune, dolutegravir, Biktarvy, Intelence, Epzicom, Prezcobix, Tivicay, Trizivir, Symfi, atazanavir, raltegravir, zidovudine, Octagam, Sustiva, Lexiva, Viramune XR, Edurant, indinavir, lamivudine / zidovudine, Ziagen, Telzir, emtricitabine / tenofovir, stavudine, Retrovir, Fuzeon, emtricitabine, Epivir, Isentress, nelfinavir, Juluca, darunavir, amprenavir, abacavir / dolutegravir / lamivudine, Carimune NF, Sandoglobulin, emtricitabine / rilpivirine / tenofovir, lopinavir / ritonavir, Iveegam En, Gamimune N 10%, Gamimune N 5%, Polygam S / D, Gammar-P IV, Venoglobulin-S 10%, Panglobulin, Gammaplex, Zerit XR, Gamimune, Gammar IV, fosamprenavir, enfuvirtide, Vitekta, Tybost, Evotaz, Dutrebis, efavirenz / emtricitabine / tenofovir, didanosine, delavirdine, abacavir / lamivudine / zidovudine, Venoglobulin-S 5%, Panglobulin NF, Gammagard S / D, emtricitabine / tenofovir alafenamide, Agenerase, emtricitabine / nelfinavir / tenofovir, ibalizumab, lamivudine / tenofovir, efavirenz / lamivudine / tenofovir, bictegravir / emtricitabine / tenofovir alafenamide, dolutegravir / rilpivirine, emtricitabine / rilpivirine / tenofovir alafenamide, Rescriptor, cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide, lamivudine / raltegravir, cobicistat / darunavir, atazanavir / cobicistat, cobicistat, elvitegravir, rilpivirine, emtricitabine / lopinavir / ritonavir / tenofovir, Videx, Selzentry, Zerit, maraviroc, saquinavir, cobicistat / elvitegravir / emtricitabine / tenofovir, Flebogamma, Hivid, Aptivus, tipranavir, Invirase, Videx EC, Fortovase, zalcitabine, Viracept, etravirine, Epivir-HBV, abacavir / lamivudine, Emtriva, Crixivan